Jun 15, 2020
Global Market for CRISPR Technology by End User, Application, Region and Key Company Profiles
Jun 09, 2020
Lexogen Launches the TraPR Kit for Isolation of Functional Small RNAs
Oct 29, 2019
New England Biolabs® helps Researchers to Tackle Transcriptomics in Bacteria and Blood with its NEBNext® Line of RNase H-based RNA Depletion Reagents
Oct 09, 2019
­­­The Threat of Multidrug Resistance: One Step Toward Unraveling the Rise of Superbacteria
Oct 01, 2019
University of California expands U.S. CRISPR-Cas9 patent portfolio with issuance of new patent
Sep 24, 2019
USPTO awards 15th U.S. CRISPR-Cas9 patent to University of California
Sep 17, 2019
University of California adds new CRISPR-Cas9 patent to growing U.S. portfolio
Sep 03, 2019
University of California granted new U.S. CRISPR-Cas9 patent related to single-guide RNA
Jun 04, 2019
University of California awarded additional U.S. patent for regulating gene editing and expression
Apr 23, 2019
Cell Microsystems Receives New NIH Grants for Automating CRISPR Workflows
Mar 20, 2019
Research Publication Suggests Metadichol® Could Reverse Age Related Diseases.
Mar 15, 2019
VGXI Announces Continued Progress for RNA Manufacturing Partnership
Mar 05, 2019
Genome Editing: Technologies and Global Markets
Feb 07, 2019
Sangamo Announces Interim Results Of Phase 1/2 CHAMPIONS Study Showing Preliminary Evidence Of In Vivo Genome Editing In Patients With MPS II Treated With SB-913
Oct 17, 2018
Global Gene Editing and Gene Therapy Market Research 2018: A New Wave of Gene Therapy Treatments to Revolutionize Treatment of Inherited Diseases
Sep 17, 2018
GeneOne Announces Expansion into RNA Vaccines and Therapeutics
Sep 17, 2018
VGXI Announces Exclusive License to Establish GMP-Grade RNA Manufacturing Services
Aug 21, 2018
Switching to CRISPR: Detailed Understanding of the Two Major Types of Adaptive Immunity to Cas9 Proteins - Humoral Immunity and Cell-Mediated Immunity
Jul 23, 2018
Sangamo Announces Treatment Of First Patient In Phase 1/2 Clinical Trial Evaluating SB-318 Investigational In Vivo Genome Editing Therapy For MPS I
Jul 17, 2018
Locus Biosciences acquires EpiBiome's high-throughput discovery platform to enhance its global leadership in CRISPR-engineered phage therapeutics